Drug Type CRISPR/Cas9 |
Synonyms HGI 003, HGI003 |
Target |
Mechanism IL-2RG gene transference |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
X-Linked Combined Immunodeficiency Diseases | Preclinical | CN | 17 Aug 2022 |